Can Ebola Vaccine Keep Virus From Taking Root?

The transcript discusses the World Health Organization's (WHO) initial reluctance to use an experimental Ebola vaccine from GlaxoSmithKline during an outbreak, focusing instead on containment. As the outbreak worsened, WHO reconsidered and sought the vaccine. The transcript covers the vaccine's development, testing, and potential availability, alongside international efforts to control the virus. It also addresses ethical concerns and challenges in distributing the vaccine, especially to healthcare workers, and the risk of the virus becoming endemic in West Africa.

What are the potential consequences if the Ebola outbreak is not controlled soon?

What ethical considerations are mentioned regarding the distribution of the vaccine during an outbreak?